Intercept Pharmaceuticals Inc.

(NASDAQ:ICPT) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.

Contact Information

Website: www.interceptpharma.com
Email: investors@interceptpharma.com
Main Phone: +1 646 747-1000
Address: 10 Hudson Yards
Address 2: 37th Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10001

Issuer Information

Exchange: NGS
CEO: Jerome B. Durso
Employees: 498
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A